Dr. Marjan Mokhtare, a distinguished gastroenterologist and faculty member at the Iran University of Medical Sciences, highlights a concerning trend in the prevalence of Helicobacter pylori infection across Iran. Recent studies indicate that the infection rate has escalated to between 50% and 60%, positioning the nation among the highest globally. This alarming statistic underscores the bacterium's persistent threat to digestive health.

Helicobacter pylori is a gram-negative bacterium known for its role in the pathogenesis of various gastrointestinal disorders, including chronic gastritis, peptic ulcers, and notably, stomach cancer. Dr. Mokhtare emphasizes the urgency of addressing this public health issue, particularly given that Iran is classified as a high-risk area for stomach cancer, with an annual incidence rate estimated between 16 to 18 cases per 100,000 people.

In light of these troubling statistics, Dr. Mokhtare advocates for a strategic approach to managing Helicobacter pylori infections. She stresses that effective control measures should be prioritized within the national healthcare framework to mitigate the potential consequences associated with this infection. This includes increased awareness, early diagnosis, and appropriate treatment protocols tailored to the Iranian population.

As the prevalence of Helicobacter pylori continues to rise, it is imperative for healthcare professionals and policymakers to collaborate in developing comprehensive strategies. By prioritizing the management of this infection, Iran can take significant steps toward reducing the burden of gastrointestinal diseases and improving overall public health outcomes.